US Patent Issued to Gilead Sciences on Sept. 9 for "Sars-cov2 main protease inhibitors" (California, Washington Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,183, issued on Sept. 9, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Sars-cov2 main protease inhibitors" was invented by Stephen E. Ammann (Foster City, Calif.), Xinpei Cai (San Mateo, Calif.), Eda Y. Canales (San Mateo, Calif.), Weng K. Chang (San Lorenzo, Calif.), Gregory F. Chin (San Francisco), Henok H. Kinfe (Foster City, Calif.), Scott E. Lazerwith (San Francisco), Jessica L McKinley (Foster City, Calif.), Michael R. Mish (Foster City, Calif.), Devan Naduthambi (San Bruno, Calif.), Jason K. Perry (San Francisco), Kevin X Rodriguez (San Mateo, Calif.), Scott D. Schroeder (Union City, Calif.), Christopher J. Swank (San Mateo, Calif.) and Joshua J. Van Veldhuiz...